| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $115.1M | — | +126.1% |
| Cost of Revenue | $15.7M | — | -11.8% |
| Gross Profit | $99.3M | — | +200.4% |
| R&D Expense | $24.7M | — | +18.4% |
| SG&A Expense | $32.0M | — | +150.8% |
| Operating Income | $29.3M | — | +273.1% |
| Pre-tax Income | $30.1M | — | +261.5% |
| Income Tax | $35.3M | — | +522.5% |
| Net Income | -$5.2M | — | +78.4% |
| EPS (Basic) | -$0.12 | — | +78.9% |
| EPS (Diluted) | -$0.12 | — | +78.9% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Short-term Investments | $2.5M | -25.9% | -34.6% |
| Accounts Receivable | $51.2M | -13.1% | +7.5% |
| Inventory | $1.2M | +9.1% | -33.3% |
| Current Assets | $186.1M | -2.4% | -7.0% |
| Total Assets | $602.0M | -4.5% | -2.5% |
| Current Liabilities | $99.2M |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $37.9M | — | +309.5% |
| Capital Expenditures | $2.2M | — | +65.4% |
| Investing Cash Flow | -$1.8M | — | -335.7% |
| Financing Cash Flow | -$27.7M | — | -2.1% |
| Free Cash Flow | $35.6M | — | +351.5% |
| -34.7% |
| Long-term Debt | $171.9M | -13.9% | -32.9% |
| Total Liabilities | $451.6M | -5.9% | -9.1% |
| Stockholders' Equity | $150.4M | -0.2% | +24.6% |